Woodline Partners’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.5M | Sell |
|
|||||
|
2025
Q1 | $42M | Sell |
|
|||||
|
2024
Q4 | $91.8M | Buy |
|
|||||
|
2024
Q3 | $126M | Buy |
|
|||||
|
2024
Q2 | $53.4M | Buy |
|
|||||
|
2024
Q1 | $26.9M | Buy |
|
|||||
|
2023
Q4 | $24.7M | Buy |
|
|||||
|
2023
Q3 | $19.4M | Sell |
|
|||||
|
2023
Q2 | $19.5M | Buy |
|
|||||
|
2023
Q1 | $9.37M | Hold |
|
|||||
|
2022
Q4 | $12M | Buy |
|
|||||
|
2022
Q3 | $4.71M | Sell |
|
|||||
|
2022
Q2 | $10.1M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $2.32M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $728K | Buy |
|